T-Cypher Bio
T-CypherBio - benefit the patient
- Business Model
- B2B
- Website
- tcypherbio.com
- Last Round
- Venture RoundFeb 2021
- Rounds
- 1
About
Mapping the immune system to design next-gen therapies
Summary
T-Cypher Bio is a Biotech company. Its most recent funding was a Venture Round in Feb 2021.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Feb 2021
Similar Companies
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/t-cypher-bio"><img src="https://indexed.vc/api/badge/company/t-cypher-bio" alt="T-Cypher Bio on Indexed.vc" width="260" height="76" /></a>